financetom
Business
financetom
/
Business
/
Toronto-Dominion Bank Credit Ratings Confirmed at DBRS
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Toronto-Dominion Bank Credit Ratings Confirmed at DBRS
May 6, 2024 7:54 AM

10:21 AM EDT, 05/06/2024 (MT Newswires) -- DBRS on Friday confirmed its credit ratings on Toronto-Dominion Bank ( MLWIQXX ) and its related entities, including the bank's long-term issuer rating of "AA (high)" and short-term issuer rating of "R-1 (high)."

The trend on all credit ratings is stable.

The bank's long-term issuer rating is composed of an intrinsic assessment of "AA" and a support assessment of "SA2," which reflects the expectation of timely systemic support from the Government of Canada.

"TD's credit ratings and Stable trends are underpinned by its strong banking franchise and diversified business mix and earnings, including its top-tier Canadian retail franchise," the rating agency said. "Additionally, the Bank has a large U.S. banking franchise operating primarily along the Eastern Seaboard, contributing to earnings diversity."

Price: 75.17, Change: +0.37, Percent Change: +0.49

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Danaher to Acquire Masimo for $180 Per Share in Cash
Danaher to Acquire Masimo for $180 Per Share in Cash
Mar 11, 2026
08:10 AM EST, 02/17/2026 (MT Newswires) -- Danaher ( DHR ) said Tuesday it has entered into a definitive agreement to acquire Masimo ( MASI ) for $180 per share in cash, or a total enterprise value of about $9.9 billion, including assumed indebtedness and net of acquired cash. Upon completion of the deal, expected in H2, Masimo ( MASI...
Janux Therapeutics Begins Dosing First Patient in Phase 1 Trial of Potential Autoimmune Disease Treatment
Janux Therapeutics Begins Dosing First Patient in Phase 1 Trial of Potential Autoimmune Disease Treatment
Mar 11, 2026
08:09 AM EST, 02/17/2026 (MT Newswires) -- Janux Therapeutics ( JANX ) said Tuesday the first participant has been dosed in a phase 1 clinical study of JANX011, a potential treatment for autoimmune diseases engineered using the company's proprietary platform. The therapy is designed to enable a reset of the immune system through targeted depletion of CD19-expressing B cells in...
Cousins Properties Authorizes $250 Million Share Repurchase Program
Cousins Properties Authorizes $250 Million Share Repurchase Program
Mar 11, 2026
08:55 AM EST, 02/17/2026 (MT Newswires) -- Cousins Properties ( CUZ ) said Tuesday its board approved a new plan to buy back as much as $250 million of the company's common stock. The real estate firm intends to finance the buybacks using cash on hand, debt, proceeds from the sale of non-core assets, or settled shares from its at-the-market...
Sector Update: Consumer
Sector Update: Consumer
Mar 11, 2026
08:56 AM EST, 02/17/2026 (MT Newswires) -- Consumer stocks were mixed premarket Tuesday, with the State Street Consumer Staples Select Sector SPDR ETF (XLP) slightly advancing and the State Street Consumer Discretionary Select Sector SPDR ETF (XLY) down 0.2%. Somnigroup International ( SGI ) shares were down more than 5% after the company reported Q4 net sales that missed analysts'...
Copyright 2023-2026 - www.financetom.com All Rights Reserved